Abstract:Nanosafety assessment has experienced an intense era of research during the past decades driven by a vivid interest of regulators, industry, and society. Toxicological assays based on in vitro cellular models have undergone an evolution from experimentation using nanoparticulate systems on singular epithelial cell models to employing advanced complex models more realistically mimicking the respective body barriers for analyzing their capacity to alter the immune state of exposed individuals. During this phase, a number of lessons were learned. We have thus arrived at a state where the next chapters have to be opened, pursuing the following objectives: (1) to elucidate underlying mechanisms, (2) to address effects on vulnerable groups, (3) to test material mixtures, and (4) to use realistic doses on (5) sophisticated models. Moreover, data reproducibility has become a significant demand. In this context, we studied the emerging concept of adverse outcome pathways (AOPs) from the perspective of immune activation and modulation resulting in pro-inflammatory versus tolerogenic responses. When considering the interaction of nanomaterials with biological systems, protein corona formation represents the relevant molecular initiating event (e.g., by potential alterations of nanomaterial-adsorbed proteins). Using this as an example, we illustrate how integrated experimental-computational workflows combining in vitro assays with in silico models aid in data enrichment and upon comprehensive ontology-annotated (meta)data upload to online repositories assure FAIRness (Findability, Accessibility, Interoperability, Reusability). Such digital twinning may, in future, assist in early-stage decision-making during therapeutic development, and hence, promote safe-by-design innovation in nanomedicine. Moreover, it may, in combination with in silico-based exposure-relevant dose-finding, serve for risk monitoring in particularly loaded areas, for example, workplaces, taking into account pre-existing health conditions. This article is categorized under: Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials.

Advanced in silico characterization of nanomaterials for nanoparticle toxicology

In Silico Nanosafety Assessment Tools And Their Ecosystem-Level Integration Prospect

Applying quantitative structure–activity relationship approaches to nanotoxicology: Current status and future potential

Predictive toxicological paradigm and high throughput approach for toxicity screening of engineered nanomaterials

Application of Machine Learning in Nanotoxicology: A Critical Review and Perspective

Computational Nanotoxicology Models for Environmental Risk Assessment of Engineered Nanomaterials

AI and Machine Learning Approaches for Predicting Nanoparticles Toxicity The Critical Role of Physiochemical Properties

Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations

Twenty years of in vitro nanotoxicology: how AI could make the difference

Creative Use of Analytical Techniques and High-Throughput Technology to Facilitate Safety Assessment of Engineered Nanomaterials

Modelling and predicting the biological effects of nanomaterials

Assessing inorganic nanoparticle toxicity through omics approaches

Nano-QSAR Modeling for Predicting the Cytotoxicity of Metallic and Metal Oxide Nanoparticles: A Review.

Nanotoxicology for safe and sustainable nanotechnology

Concept of Assessing Nanoparticle Hazards Considering Nanoparticle Dosemetric and Chemical/biological Response Metrics.

Artificial Intelligence and Machine Learning Empower Advanced Biomedical Material Design to Toxicity Prediction

Systematic and mechanistic analysis of AuNP-induced nanotoxicity for risk assessment of nanomedicine

Biophysical interaction, nanotoxicology evaluation, and biocompatibility and biosafety of metal nanoparticles

Toxicity profiling of engineered nanomaterials via multivariate dose-response surface modeling

In Silico Assessment of Nanoparticle Toxicity Powered by the Enalos Cloud Platform: Integrating Automated Machine Learning and Synthetic Data for Enhanced Nanosafety Evaluation

Cytotoxicity prediction of nano metal oxides on different lung cells via Nano-QSAR